NextFin news, Merck, the global pharmaceutical company, announced on Wednesday that it is abandoning its plans to establish a £1 billion research center in London, United Kingdom.
The decision was made due to concerns over the current UK government policies, which Merck indicated were not conducive to supporting such a large-scale investment in research and development.
The planned research center was expected to be a major hub for innovation and scientific advancement, but the company cited policy uncertainties and regulatory challenges as key factors influencing its withdrawal.
This announcement was reported by La Libre on Wednesday, September 10, 2025, highlighting the impact of government policy on international business investments.
Merck's cancellation reflects broader concerns among multinational corporations about the UK's business environment amid evolving political and economic conditions.
Explore more exclusive insights at nextfin.ai.